Zimmer Biomet Holdings (XSWX:ZBH) FFO


XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
65 GF Score
Price CHF70.00
GF Value CHF97.46
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings FFO?

FFO (Funds from operations) only applies to REITs.

XSWX:ZBH
65GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF70.00 is trading 28.2% below its estimated GF Value™ of CHF97.46. GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.

Key valuation signals for XSWX:ZBH:

  • FFO:
  • GF Value™: CHF97.46 vs. price of CHF70.00 (28.2% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
65GF Score

Get the complete analysis for XSWX:ZBH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF70.00
Price
CHF97.46
GF Value